Wells Fargo Initiates Coverage On MorphoSys with Overweight Rating, Announces Price Target of $17
Portfolio Pulse from richadhand@benzinga.com
Wells Fargo analyst Derek Archila initiates coverage on MorphoSys (NASDAQ:MOR) with an Overweight rating and a price target of $17.
June 16, 2023 | 11:21 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo initiates coverage on MorphoSys with an Overweight rating and a price target of $17.
The initiation of coverage by Wells Fargo with an Overweight rating and a price target of $17 indicates a positive outlook for MorphoSys. This news is likely to have a positive impact on the stock price in the short term as it reflects the analyst's confidence in the company's potential growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100